Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Patient-tailored Microperimetry Grids for Focal Lesions in Intermediate AMD: A PINNACLE Study Report
Author Affiliations & Notes
  • Stefan Futterknecht
    Institute of Molecular and Clinical Ophthalmology Basel, Basel, Basel-Stadt, Switzerland
    Department of Ophthalmology, Universitatsspital Basel, Basel, BS, Switzerland
  • Maximilian Pfau
    Institute of Molecular and Clinical Ophthalmology Basel, Basel, Basel-Stadt, Switzerland
    Department of Ophthalmology, Universitatsspital Basel, Basel, BS, Switzerland
  • Philipp Anders
    Institute of Molecular and Clinical Ophthalmology Basel, Basel, Basel-Stadt, Switzerland
    Department of Ophthalmology, Universitatsspital Basel, Basel, BS, Switzerland
  • Julia Mai
    Laboratory of Ophthalmic Image Analysis, Medizinische Universitat Wien, Wien, Wien, Austria
  • Ursula Hall
    Institute of Molecular and Clinical Ophthalmology Basel, Basel, Basel-Stadt, Switzerland
    Department of Ophthalmology, Universitatsspital Basel, Basel, BS, Switzerland
  • Hrvoje Bogunovic
    Laboratory of Ophthalmic Image Analysis, Medizinische Universitat Wien, Wien, Wien, Austria
  • Lars Fritsche
    Center for Statistical Genetics, Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan, United States
  • Daniel Rueckert
    Imperial College London, London, London, United Kingdom
    Klinikum rechts der Isar der Technischen Universitat Munchen, Munchen, Bayern, Germany
  • Ursula Schmidt-Erfurth
    Laboratory of Ophthalmic Image Analysis, Medizinische Universitat Wien, Wien, Wien, Austria
  • Sobha Sivaprasad
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    Institute of Ophthalmology, University College London, London, United Kingdom
  • Andrew Lotery
    University of Southampton Faculty of Medicine, Southampton, United Kingdom
  • Hendrik P Scholl
    Institute of Molecular and Clinical Ophthalmology Basel, Basel, Basel-Stadt, Switzerland
    Department of Ophthalmology, Universitatsspital Basel, Basel, BS, Switzerland
  • Footnotes
    Commercial Relationships   Stefan Futterknecht None; Maximilian Pfau Apellis Pharmaceuticals, Johnson & Johnson, Code C (Consultant/Contractor), Apellis Pharmaceuticals, Code F (Financial Support), Novartis, Code R (Recipient); Philipp Anders Bayer, Code F (Financial Support); Julia Mai None; Ursula Hall None; Hrvoje Bogunovic None; Lars Fritsche None; Daniel Rueckert None; Ursula Schmidt-Erfurth None; Sobha Sivaprasad AbbVie, Amgen, Apellis, Bayer, Biogen, Boehringer Ingelheim, Novartis, Eyebiotech, Eyepoint Phamaceuticals, Janssen Pharmaceuticals, Nova Nordisk, Optos, Ocular Therapeutix, Kriya Therapeutics, OcuTerra, Roche, Stealth Biotherapeutics, Sanofi, Code F (Financial Support); Andrew Lotery None; Hendrik Scholl Alnylam Pharmaceuticals Inc., Belite Bio, Boehringer Ingelheim Pharma GmbH & Co, Droia NV, Eluminex Biosciences, F. Hoffmann-La Roche Ltd, Gerson Lehrman Group Inc., Guidepoint Global LLC, Gyroscope Therapeutics Ltd., Janssen Research & Development LLC (Johnson & Johnson), Novo Nordisk, Okuvision GmbH, ReVision Therapeutics Inc., Saliogen Therapeutics Inc., Tenpoint Therapeutics, ViGeneron, Code C (Consultant/Contractor), Kinarus AG; Okuvision GmbH; Novartis Pharma AG, Code F (Financial Support)
  • Footnotes
    Support  Wellcome Trust Grant 210572/Z/18/Z
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4386. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stefan Futterknecht, Maximilian Pfau, Philipp Anders, Julia Mai, Ursula Hall, Hrvoje Bogunovic, Lars Fritsche, Daniel Rueckert, Ursula Schmidt-Erfurth, Sobha Sivaprasad, Andrew Lotery, Hendrik P Scholl; Patient-tailored Microperimetry Grids for Focal Lesions in Intermediate AMD: A PINNACLE Study Report. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4386.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Standard microperimetry grids may underestimate the effect of focal lesions on retinal sensitivity. This study tested the hypothesis that patient-tailored microperimetry grids improve the assessment of focal lesions in individuals with intermediate age-related macular degeneration (iAMD).

Methods : In the longitudinal, prospective, multicenter PINNACLE study, patients underwent standardized microperimetry testing (24 points covering the macula). Incident focal events (FEs, including focal drusen regression, ellipsoid zone/interdigitation zone (EZ/IZ) loss with hypertransmission, and new onset intra- or subretinal fluid) were diagnosed by optical coherence tomography in an automated way. They triggered additional testing with a targeted 5-point focal grid (Fig. 1). To date, 28 eyes from 26 patients experiencing a total of 34 FEs were analyzed. To impute the local sensitivity before the incident FE, we applied generalized additive models. A linear mixed model was used to compare the longitudinal change in retinal sensitivity measured with focal grids against the change (at the same location) imputed from the standard grids.

Results : The large 24-point grids underestimated sensitivity loss in cases of EZ/IZ loss with hypertransmission by 1.20 dB (SE = 0.30 dB, p < 0.0001) compared to the 5-point focal grids. Furthermore, EZ/IZ loss with hypertransmission caused a significant sensitivity loss of 1.99 dB (SE = 0.61 dB, p < 0.05) in the affected retinal area. Notably, the impact of focal drusen regression and subretinal fluid on retinal sensitivity was not significant. Accordingly, underestimation of retinal sensitivity loss measured by 24-point grids was not apparent for these lesions.

Conclusions : The study demonstrates the utility of patient-tailored focal grids in capturing finer details of retinal sensitivity changes compared to standard 24-point grids. Specifically, EZ/IZ loss with hypertransmission emerges as a critical factor contributing to sensitivity loss in iAMD. These findings highlight the importance of incorporating focal grids in MP assessments to better understand the progression of retinal function loss in AMD.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Fig. 1: A: 24-point microperimetry grid as measured at baseline and after focal events. B: Two 5-point focal grids measured at the locations of focal events.

Fig. 1: A: 24-point microperimetry grid as measured at baseline and after focal events. B: Two 5-point focal grids measured at the locations of focal events.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×